MedTrace Logo

External Validation of the 4C Mortality Score for Hospitalised Patients With COVID-19 in a Tunisian Cohort

NCT05498324 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2023-05-16

No results posted yet for this study

Summary

Risk prediction scores are important tools to support clinical decision-making for patients with coronavirus disease (COVID-19). The objective of this paper was to validate the 4C mortality score, originally developed in the United Kingdom, for a tunisian population, and to examine its performance over time.

Conditions

  • COVID-19 Pandemic

Sponsors & Collaborators

  • University of Monastir

    lead OTHER

Principal Investigators

  • Bel Haj Ali Khaoula, MD · CHU Fattouma Bourguiba Monastir, service des urgences

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05498324 on ClinicalTrials.gov